"Our state-of-the-art facility in Broward County (South Florida) provides our physicians with access to national resources to treat all types of cancer, including but not limited to breast cancer, colon cancer, lung cancer, pancreatic cancer and prostate cancer. Holy Cross Hospital’s Michael and Dianne Bienes Comprehensive Cancer Center in Fort Lauderdale, Florida is accredited by the American College of Surgeons Commission on Cancer, the National Accreditation Program for Breast Centers (NAPBC)."

During the past decade, Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 39 clinical trials were completed, i.e. on average, 433.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 11 clinical trials were completed. i.e. 220% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 27 trials, followed by "Radiation Therapy Oncology Group" with 10 trials sponsored, "SWOG Cancer Research Network" with 6 trials sponsored, "NSABP Foundation Inc" with 5 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 58 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "NCIC Clinical Trials Group" with 5 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator and "Cancer and Leukemia Group B" with 2 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital" are "Breast Cancer" (15 trials), "Lung Cancer" (10 trials), "Lymphoma" (5 trials), "Prostate Cancer" (5 trials) and "Colorectal Cancer" (4 trials). Many other conditions were trialed in "Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital" in a lesser frequency.

Most popular intervention types in "Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital" are "Drug" (52 trials), "Biological" (18 trials), "Other" (18 trials), "Radiation" (14 trials) and "Procedure" (9 trials). Other intervention types were less common.

The name of intervention was led by "cisplatin" (10 trials), "cyclophosphamide" (6 trials), "docetaxel" (6 trials), "placebo" (6 trials) and "radiation therapy" (6 trials). Other intervention names were less common.

The vast majority of trials in "Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital" are 50 trials for "All" genders, 15 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital". undefined are not yet recruiting, 4 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 48 completed trials in Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital, 5 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 41 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".